Variations in the Chondroitin Sulfate-Protein Linkage Region of Aggrecans from Bovine Nasal and Human Articular Cartilages*

  1. Fang Cheng,
  2. Dick Heinegård,
  3. Lars-Åke Fransson,
  4. Michael Bayliss,
  5. Julie Bielicki,
  6. John Hopwood and
  7. Keiichi Yoshida
  1. From the Department of Cell and Molecular Biology, Lund University, S-221 00 Lund, Sweden
  2. From the Kennedy Institute of Rheumatology, 6 Bute Gardens, Hammersmith, London W6 7DW, United Kingdom
  3. From the Department of Chemical Pathology, Adelaide Children's Hospital, 72 King William Road, North Adelaide 5006, Australia
  4. From the Tokyo Research Institute, Seikagaku Corporation, Higashiyamato-shi, Tokyo 207, Japan
  1. To whom correspondence should be addressed:
    Dept. of Cell and Molecular Biology, Section of Cell and Matrix Biology, P. O. Box 94, S-221 00 Lund, Sweden
    . Tel.: 46-46-222-3315; Fax: 46-46-222-3128.

Abstract

Aggrecan-derived chondroitin sulfate (CS) chains, released by β-elimination, were derivatized with p-aminobenzoic acid or p-aminophenol; radioiodinated; and subjected to graded or complete degradations by chondroitin ABC lyase to generate linkage region fragments of the basic structure ΔGlyUA-GalNAc-GlcUA-Gal-Gal-Xyl-R (where ΔGlyUA represents 4,5-unsaturated glycuronic acid, and R is the adduct), by chondroitin AC lyase to generate the shorter fragment ΔGlyUA-Gal-Gal-Xyl-R, or by chondroitin C lyase to generate the same fragment when it was linked to a 6-O-sulfated or unsulfated GalNAc at the nonreducing end. Fragments were separated by size using gel chromatography, by charge using ion-exchange chromatography, and by size/charge using electrophoresis and then characterized by stepwise degradations from the nonreducing end by using mercuric acetate to remove all terminal ΔGlyUA, by bacterial glycuronidase to remove the same residue when linked to unsulfated or 6-O-sulfated GalNAc/Gal, by mammalian 4-sulfatase to remove sulfate from terminal GalNAc 4-O-sulfate, by chondro-4-sulfatase to remove 4-O-sulfate from other GalNAc/Gal residues, and by β-galactosidase to remove terminal Gal. Results with CS from bovine nasal cartilage aggrecan show that, in nearly all chains, Xyl and probably also the first Gal are unsubstituted, whereas the second Gal is 4-O-sulfated in one CS chain out of five. The first disaccharide repeat is sulfated at C-4 of GalNAc in one chain out of three and unsulfated in the other two. A sulfated first disaccharide is always joined to an unsulfated GlcUA-Gal-Gal sequence. In contrast, CS from human articular cartilage usually has a sulfated first disaccharide repeat. In CS from young human cartilage, sulfate groups are mostly at C-4 of GalNAc in the major part of the chain, but at C-6 in the nonreducing distal portion. In CS from old cartilage, sulfation at C-6 of GalNAc is a major feature from the nonreducing end down to approximately positions 4 and 5 from the linkage region, where GalNAc 4-O-sulfate is common.

Footnotes

  • * This work was supported by the Swedish Medical Research Council, the Swedish Society for Medical Research, the “Gustaf V:s 80-Års Fond,” the Kock and österlund Foundations, and the Medical Faculty of Lund University. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    GAG

    glycosaminoglycan

    CS

    chondroitin sulfate

    DS

    dermatan sulfate

    GlyUA

    glycuronic (hexuronic) acid

    ΔGlyUA

    4,5-unsaturated GlyUA

    IdoUA

    iduronic acid

    4S

    4-O-sulfate

    6S

    6-O-sulfate.

    • Received March 18, 1996.
    • Revision received June 26, 1996.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement